Search research articles
Contact Us
Filters
Showing results (1-10 of 416) with videos related to
Page
of 42
Sort By:
Cancer Cell
|
April 13, 2016
Interfering with CCL5/CCR5 at the Tumor-Stroma Interface
Vincenzo Bronte, Emilio Bria
Cancer Immunology Research
|
August 8, 2025
Unlocking the Immune Response in ALK-Rearranged Lung Adenocarcinoma
Antonio Vitale, Emilio Bria
ESMO Open
|
December 21, 2017
Biosimilars as a strategy to improve sustainability
Emilio Bria, Pierfranco Conte
JAMA Network Open
|
July 11, 2023
Is Immunotherapy With Concomitant Proton Pump Inhibitor Use a Viable Combination?
Alessio Stefani, Emilio Bria
The New England Journal of Medicine
|
February 5, 2005
Chemoradiotherapy for rectal cancer
Gianluigi Ferretti, Emilio Bria, Mario Mandalà
Annals of Translational Medicine
|
August 15, 2020
Looking for a better measure of the benefit in clinical trials: a never-ending journey
Gennaro Daniele, Diana Giannarelli, Emilio Bria
The New England Journal of Medicine
|
October 7, 2005
Treatment of resected non-small-cell lung cancer
Emilio Bria, Diana Giannarelli, Edmondo Terzoli
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 2008
Thalidomide in small-cell lung cancer: is it a tombstone?
Antonio Rossi, Cesare Gridelli, Emilio Bria
JAMA Network Open
|
November 3, 2025
Personalizing Adjuvant Endocrine Therapy for Breast Cancer
Letizia Pontolillo, Luisa Carbognin, Emilio Bria
The New England Journal of Medicine
|
December 15, 2006
DNA repair by ERCC1 in non-small-cell lung cancer
Fabiana Cecere, Emilio Bria, Rafael Rosell
Page
of 42
Search research articles
Search
Showing results (1-10 of 416) with videos related to
Sort By:
Page
of 42
Cancer Cell
|
April 13, 2016
Interfering with CCL5/CCR5 at the Tumor-Stroma Interface
Vincenzo Bronte, Emilio Bria
Cancer Immunology Research
|
August 8, 2025
Unlocking the Immune Response in ALK-Rearranged Lung Adenocarcinoma
Antonio Vitale, Emilio Bria
ESMO Open
|
December 21, 2017
Biosimilars as a strategy to improve sustainability
Emilio Bria, Pierfranco Conte
JAMA Network Open
|
July 11, 2023
Is Immunotherapy With Concomitant Proton Pump Inhibitor Use a Viable Combination?
Alessio Stefani, Emilio Bria
The New England Journal of Medicine
|
February 5, 2005
Chemoradiotherapy for rectal cancer
Gianluigi Ferretti, Emilio Bria, Mario Mandalà
Annals of Translational Medicine
|
August 15, 2020
Looking for a better measure of the benefit in clinical trials: a never-ending journey
Gennaro Daniele, Diana Giannarelli, Emilio Bria
The New England Journal of Medicine
|
October 7, 2005
Treatment of resected non-small-cell lung cancer
Emilio Bria, Diana Giannarelli, Edmondo Terzoli
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 2008
Thalidomide in small-cell lung cancer: is it a tombstone?
Antonio Rossi, Cesare Gridelli, Emilio Bria
JAMA Network Open
|
November 3, 2025
Personalizing Adjuvant Endocrine Therapy for Breast Cancer
Letizia Pontolillo, Luisa Carbognin, Emilio Bria
The New England Journal of Medicine
|
December 15, 2006
DNA repair by ERCC1 in non-small-cell lung cancer
Fabiana Cecere, Emilio Bria, Rafael Rosell
Page
of 42